Tryp Therapeutics Provides Update on Plan of Arrangement With Exopharm Limited and Announces Voluntary Trading Halt - Seite 3
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPTED RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Lesen Sie auch
SOURCE: Tryp Therapeutics, Inc.
View the original press release on accesswire.com
The Tryp Therapeutics Stock at the time of publication of the news with a raise of +1,28 % to 0,040EUR on Lang & Schwarz stock exchange (24. April 2024, 12:04 Uhr).
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte